María Aldana Vissani

Dr. María Aldana Vissani

Instituto de Virología CICVyA, Instituto Nacional de Tecnología Agropecuaria (INTA)
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2019 in Equine Veterinary Journal
Verified
Journal Article
Closed access
PDF file
CPCecilia Olguin Perglione
Cecilia Olguin Perglione
MVMaría Aldana Vissani
María Aldana Vissani
FAF. Alamos
F. Alamos
MTM. S. Tordoya
M. S. Tordoya
MBM. Barrandeguy
M. Barrandeguy

1 January 2016 in The Veterinary Journal
Verified
Journal Article
Closed access
MVMaría Aldana Vissani
María Aldana Vissani
ETEtienne Thiry
Etienne Thiry
FPFabiana Dal Pozzo
Fabiana Dal Pozzo
MBMaría Barrandeguy
María Barrandeguy

8 May 2025 in Veterinary Microbiology
Verified
Journal Article
Open access
CTCôme Julian, Maxence Thieulent
Côme Julian, Maxence Thieulent
MCMariano Carossino
Mariano Carossino
JRJenner Reis
Jenner Reis
MVMaría Aldana Vissani
María Aldana Vissani
MBMaria Edith Barrrandeguy
Maria Edith Barrrandeguy
UBUdeni Balasuriya
Udeni Balasuriya
Equine Infectious Anemia Virus (EIAV), the causative agent of Equine Infectious Anemia (EIA), presents a significant threat to equine populations worldwide. While local EIAV prevalence has been estimated in several studies, no global prevalence has been determined. Thus, this study aimed to review the literature on EIAV prevalence in the 21st century. A comprehensive electronic search was conducted in PubMed, Web of Science, Scopus, Google Scholar, SciELO.org, African Journals Online, and NZresearch.org, yielding 105 articles published between January 1st, 2000, and December 31st, 2024 (spanning 24 years). EIAV prevalence was estimated in 42 countries and is particularly high in Mexico (North America; 27.14 % [95 % CI, 25.11 - 29.17]) and Guatemala (Central America; 15.9 % [95 % CI, 9.66 - 22.14]). While EIAV prevalence in the United States of America (USA) remains low and stable over time, the relatively elevated prevalence in the Southern states, along with their extensive border with Mexico, places these areas at a higher risk. EIAV prevalence estimated per province/state in the USA, Argentina, and Brazil, indicated higher rates in humid and warmer regions. EIAV has a low presence in the Middle East, while the scarcity of epidemiological studies in Africa and Oceania complicates the estimation of EIAV prevalence in these regions. These findings highlight the need for continued intensive surveillance in both high-risk regions and areas lacking data. Given that insect vectors are the primary natural transmission route, global warming may lead to increased vector movement into temperate areas, potentially contributing to a surge in EIAV infections.

16 January 2024 in Viruses
Verified
Journal Article
Open access
PDF file
MCMariano Carossino
Mariano Carossino
MVMaría Aldana Vissani
María Aldana Vissani
MBMaria E. Barrandeguy
Maria E. Barrandeguy
UBUdeni Balasuriya
Udeni Balasuriya
VPViviana Parreño
Viviana Parreño
Group A rotaviruses are a well-known cause of viral gastroenteritis in infants and children, as well as in many mammalian species and birds, affecting them at a young age. This group of viruses has a double-stranded, segmented RNA genome with high genetic diversity linked to point mutations, recombination, and, importantly, reassortment. While initial molecular investigations undertaken in the 1900s suggested host range restriction among group A rotaviruses based on the fact that different gene segments were distributed among different animal species, recent molecular surveillance and genome constellation genotyping studies conducted by the Rotavirus Classification Working Group (RCWG) have shown that animal rotaviruses serve as a source of diversification of human rotavirus A, highlighting their zoonotic potential. Rotaviruses occurring in various animal species have been linked with contributing genetic material to human rotaviruses, including horses, with the most recent identification of equine-like G3 rotavirus A infecting children. The goal of this article is to review relevant information related to rotavirus structure/genomic organization, epidemiology (with a focus on human and equine rotavirus A), evolution, inter-species transmission, and the potential zoonotic role of equine and other animal rotaviruses. Diagnostics, surveillance and the current status of human and livestock vaccines against RVA are also reviewed.

10 October 2024 in Viruses
Verified
Journal Article
Open access
PDF file
MVMaría Aldana Vissani
María Aldana Vissani
FAFlorencia Alamos
Florencia Alamos
MTMaria Silvia Tordoya
Maria Silvia Tordoya
LMLeonardo Minatel
Leonardo Minatel
JSJuan Manuel Manuel Schammas
Juan Manuel Manuel Schammas
MCMariano Carossino
Mariano Carossino
Western equine encephalitis virus (WEEV) is a mosquito-borne arbovirus (genus Alphavirus, family Togaviridae) that has re-emerged in South America in late 2023, causing severe disease in both horses and humans after a nearly 40-year intermission period. We here describe the virological, serological, pathological, and molecular features of WEEV infection in horses during the 2023–2024 outbreak in Argentina. WEEV-infected horses developed neurological signs with mild to severe encephalitis associated with minimal to abundant WEEV-infected cells, as demonstrated by WEEV-specific in situ hybridization. The distribution of viral RNA was multifocal, with predominance within neuronal bodies, neuronal processes, and glial cells in the medulla oblongata and thalamic regions. Phylogenetic analysis of partial nsP4 sequences from three viral isolates obtained from three different provinces of Argentina support grouping with other temporally current WEEV strains from Uruguay and Brazil under a recently proposed novel lineage.

20 August 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
MVMaría Aldana Vissani
María Aldana Vissani
ADarmando damiani
armando damiani
MBMaría Edith Barrandeguy
María Edith Barrandeguy
Equine coital exanthema (ECE) is a highly contagious, venereally-transmitted mucocutaneous disease, characterized by the formation of papules, vesicles, pustules and ulcers on the external genital organs of mares and stallions, and caused by equid alphaherpesvirus 3 (EHV-3). The infection is endemic worldwide and the virus is transmitted mainly through direct contact during sexual intercourse and by contaminated instruments during reproductive maneuvers in breeding facilities. The disease does not result in systemic illness, infertility or abortion, yet it does have a negative impact on the equine industry as it forces the temporary withdrawal of affected animals with the consequent disruption of mating activities in breeding facilities. The purpose of this review is to provide up-to-date relevant information on the knowledge of EHV-3 infection and to analyze new approaches on diagnostics, treatment and prevention in the interest of minimizing the negative consequences of ECE in light of the current situation of the equine industry.